Gan Zhongru

Early Life

Gan Zhongru was born in China and holds a Ph.D. from Michigan State University. Before embarking on his entrepreneurial journey, he gained experience working at Merck.

Rise to Success

In 1998, Gan Zhongru co-founded Gan & Lee Pharmaceuticals. The company, headquartered in Beijing, specializes in the development, production, and commercialization of insulin analogs and medical devices. Gan & Lee was the first Chinese company to master the technology for industrial-scale production of recombinant insulin analogs, establishing a leading position in the Chinese diabetes market. The company's industrial park covers approximately 200,000 square meters and employs over 5,500 people globally. Gan & Lee's success is also reflected in its collaborations with international partners like Sandoz, and its expansion into global markets.

Key Business Strategies

Gan & Lee focuses on innovation, producing the first Chinese domestic insulin analog. The company aims to become a trusted leader in the global pharmaceutical industry through innovative processes, business practices, and products. Gan & Lee has a mission to improve global health by providing valuable treatment options and reducing costs.

Philanthropy

Specific philanthropy amounts are not readily available in the search results, though the company's mission includes improving the quality of human life and improving global health. Gan & Lee is committed to providing scientific solutions to patients across the globe.